NCT05259046View on ClinicalTrials.gov

The InterVitaminK Trial - Effects of Vitamin K Supplementation on Cardiovascular, Metabolic, and Bone Health

NARecruitingINTERVENTIONAL
Enrollment

450

Participants

Timeline

Start Date

June 21, 2022

Primary Completion Date

October 1, 2026

Study Completion Date

December 1, 2026

Conditions
Coronary Artery CalcificationArterial Stiffness
Interventions
DIETARY_SUPPLEMENT

Menaquinone-7 (MK-7) tablet (333 µg)

One MK-7 tablet containing 333 µg MK-7 per day

DIETARY_SUPPLEMENT

Placebo tablet

One placebo tablet per day

Trial Locations (1)

DK-2600

RECRUITING

Center for Clinical Research and Prevention, Copenhagen

All Listed Sponsors
lead

Bispebjerg Hospital

OTHER